3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend

Bulletin Express

08/17

3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes:

1. Approval of the unaudited interim results for the six months ended 30 June 2026. 2. Consideration of an interim dividend, if any.

Board Composition (as of the announcement date, 17 August 2026): • Executive Director and Chairman: Dr. Gong Zhaolong • Non-Executive Directors: Ms. Zhang Wenhua, Mr. Zhou Feng, Ms. Chen Yawen • Independent Non-Executive Directors: Dr. Li Jin, Dr. Lin Tat Pang, Mr. Liu Xinguang

The notice was issued in Hong Kong on 17 August 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1143007118"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143007118\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143007118?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 21:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143007118","market":"hk","top_or_hot":-1,"title":"3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend","media":"Bulletin Express","content":"<p>3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes:</p>\n<p>1. Approval of the unaudited interim results for the six months ended 30 June 2026.  \n2. Consideration of an interim dividend, if any.</p>\n<p>Board Composition (as of the announcement date, 17 August 2026):  \n• Executive Director and Chairman: Dr. Gong Zhaolong  \n• Non-Executive Directors: Ms. Zhang Wenhua, Mr. Zhou Feng, Ms. Chen Yawen  \n• Independent Non-Executive Directors: Dr. Li Jin, Dr. Lin Tat Pang, Mr. Liu Xinguang</p>\n<p>The notice was issued in Hong Kong on 17 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-17 21:45</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes:</p>\n<p>1. Approval of the unaudited interim results for the six months ended 30 June 2026.  \n2. Consideration of an interim dividend, if any.</p>\n<p>Board Composition (as of the announcement date, 17 August 2026):  \n• Executive Director and Chairman: Dr. Gong Zhaolong  \n• Non-Executive Directors: Ms. Zhang Wenhua, Mr. Zhou Feng, Ms. Chen Yawen  \n• Independent Non-Executive Directors: Dr. Li Jin, Dr. Lin Tat Pang, Mr. Liu Xinguang</p>\n<p>The notice was issued in Hong Kong on 17 August 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01244","symbol_name":"思路迪醫藥股份","start_time":0,"source_url":"","article_id":"1143007118","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143007118","pubTimestamp":1786974313,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes: 1. Approval of the unaudited interim results for the six months ended 30 June 2026.   2. Consideration...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01244":"思路迪医药股份"},"translate_title":"3D Medicines 定于 2026 年 8 月 31 日召开董事会会议，审查 2026 年上半年业绩和潜在中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01244":1},"content_text":"3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes:\n1. Approval of the unaudited interim results for the six months ended 30 June 2026.  \n2. Consideration of an interim dividend, if any.\nBoard Composition (as of the announcement date, 17 August 2026):  \n• Executive Director and Chairman: Dr. Gong Zhaolong  \n• Non-Executive Directors: Ms. Zhang Wenhua, Mr. Zhou Feng, Ms. Chen Yawen  \n• Independent Non-Executive Directors: Dr. Li Jin, Dr. Lin Tat Pang, Mr. Liu Xinguang\nThe notice was issued in Hong Kong on 17 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}